Trial · NCT07595237
A IIT Study of 177Lu-DOTA-SNA040
NCT07595237, Early phase 1, Recruiting, SmartNuclide Biopharma
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A IIT Study of 177Lu-DOTA-SNA040. Trials, record NCT07595237. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07595237
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A IIT Study of 177Lu-DOTA-SNA040
- NCT number
- NCT07595237
- Status
- Recruiting
- Phases
- Early phase 1
- Enrollment
- 12 participants, estimated
- Lead sponsor
- SmartNuclide Biopharma
- Conditions
Advanced Solid Tumors (Such as Gastric Cancer), Advanced Solid Tumors (Such as Adenocarcinoma at the Gastroesophageal Junction), Advanced Solid Tumors (Such as Pancreatic Cancer), Advanced Solid Tumors (Such as Cholangiocarcinoma)
- Interventions
- 177Lu-DOTA-SNA040
- First posted
- 2026-05-19
- Last updated
- 2026-08-21
Source ClinicalTrials.gov
Registered outcomes21
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Dose-limiting toxicity(DLT) of the single dose | 4 to 6weeks | Occurance of DLT in the first cycle of each group |
| Primary | The safety and tolerance of 177Lu-DOTA-SNA040 | 4 to 6 weeks | The occurance and stage of AE and SAE according to CTCAE |
| Primary | The safety and tolerance of 177Lu-DOTA-SNA040 | 4 to 6 weeks | The rates of abnormal laborotary tests after administration |
| Primary | The safety and tolerance of 177Lu-DOTA-SNA040 | 4 to 6 weeks | The rates of abnormal vital signs after administration |
| Primary | The safety and tolerance of 177Lu-DOTA-SNA040 | 4 to 6 weeks | The rates of abnormal physical examination after administration |
| Primary | The safety and tolerance of 177Lu-DOTA-SNA040 | 4 to 6 weeks | The rates of abnormal 12-lead ECG after administration |
| Secondary | The biodistribution of SNA040 | 1 week | Absorbed dose in major organs throughout the body (red bone marrow, kidneys, liver, intestines, etc.) |
| Secondary | The tumor uptake of SNA040 | 1 week | SUVmax and SUVmean of tumor |
| Secondary | The tumor uptake of SNA040 | 1 week | The retention time of tumor |
| Secondary | The tumor uptake of SNA040 | 1 week | The ID% of tumor |
1 to 10 of 21Source ClinicalTrials.gov
See all 21 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07595237
GET https://conductscience.org/api/trials/v1/NCT07595237/registered?page=2